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Structural analysisProtein translocation into the endoplasmic reticulum (ER) is the ﬁrst and decisive step in the biogenesis of
most extracellular and many soluble organelle proteins in eukaryotic cells. It is mechanistically related to
protein export from eubacteria and archaea and to the integration of newly synthesized membrane proteins
into the ER membrane and the plasma membranes of eubacteria and archaea (with the exception of tail
anchored membrane proteins). Typically, protein translocation into the ER involves cleavable amino terminal
signal peptides in precursor proteins and sophisticated transport machinery components in the cytosol, the
ER membrane, and the ER lumen. Depending on the hydrophobicity and/or overall amino acid content of the
precursor protein, transport can occur co- or posttranslationally. The respective mechanism determines the
requirements for certain cytosolic transport components. The two mechanisms merge at the level of the ER
membrane, speciﬁcally, at the heterotrimeric Sec61 complex present in the membrane. The Sec61 complex
provides a signal peptide recognition site and forms a polypeptide conducting channel. Apparently, the Sec61
complex is gated by various ligands, such as signal peptides of the transport substrates, ribosomes (in
cotranslational transport), and the ER lumenal molecular chaperone, BiP. Binding of BiP to the incoming
polypeptide contributes to efﬁciency and unidirectionality of transport. Recent insights into the structure of
the Sec61 complex and the comparison of the transport mechanisms and machineries in the yeast
Saccharomyces cerevisiae, the human parasite Trypanosoma brucei, and mammals have various important
mechanistic as well as potential medical implications. This article is part of a Special Issue entitled Protein
translocation across or insertion into membranes.binding protein; EM, electron microscopy; ER, end
tein; Hsp, heat shock protein; NAC, nascent chain associa
tein; Sec, protein or complex that is involved in protein
translocation across or insertion into membranes.
: +49 6841 1626288.
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Protein translocation into the endoplasmic reticulum (ER) is the
ﬁrst step in the biogenesis of most extracellular and many soluble
organelle proteins of eukaryotic cells (such as resident proteins of the
ER, ER-Golgi intermediate compartment/ERGIC, Golgi, endosome, and
lysosome) [1–3]. Typically, protein translocation into the ER involves
cleavable amino terminal signal peptides in precursor proteins and
sophisticated transport machinery. The signal peptides for ER
targeting are 15 to 30 amino acid residues in length and have a
tripartite organization, comprised of a core of hydrophobic residues
ﬂanked by a positively charged aminoterminal and a polar, but
uncharged carboxyterminal region [4–8]. Two mechanisms can be
distinguished that differ in their relationship to translation (termed
co- and posttranslational mechanisms) and with respect to the
relevant cytosolic components. The two mechanisms merge at the ER
membrane, speciﬁcally at the heterotrimeric Sec61 complex that
comprises α-, β-, and γ-subunits. In addition, they involve further
components, most notably the ER-lumenal chaperone BiP and its co-
chaperones and nucleotide exchange factors (NEFs). During or
immediately after translocation, the precursors are typically pro-
cessed on the lumenal face of the ER membrane by the signal
peptidase complex (SPC) [9–15], oligosaccharyl transferase (OST)
[15–21], and/or GPI transamidase [22–29]. However, processing by
these enzymes is not a prerequisite for transport into the ER.
In general, protein translocation into the ER is followed by folding
and assembly of the newly-imported polypeptides. Folding and
assembly of proteins involve some of the above-mentioned compo-
nents, such as BiP and its co-chaperones and nucleotide exchange
factors [30–39]. After folding and assembly, the native proteins are
delivered to their functional location by vesicular transport (with the
exception of resident ER proteins). In the case of mis-folding or mis-
assembly, the polypeptides are exported to the cytosol and delivered
to the proteasome for degradation (termed ERAD) [Sommer, this
issue]. The export of somemis-folded polypeptides from the ER lumen
to the cytosol also involves some of the above-mentioned compo-
nents, such as the Sec61 complex and BiP [40–49].
2. Co- and posttranslational transport mechanisms
Protein transport into the ER can occur co- or posttranslationally.
The cytosolic transport components are dedicated either to cotransla-
tional (signal recognition particle, SRP) or posttranslational (heat
shock proteins, Hsp) transport (Table 1). In posttranslational
transport, fully synthesized precursor polypeptides are transported
with the help of cytosolic molecular chaperones, belonging to the
Hsp70 and Hsp40 chaperone families [50–54]. By cycling on and off,
the chaperones keep the precursor polypeptides soluble and
competent for interaction with the transport components in the ER-
membrane. In cotranslational transport, nascent precursor polypep-
tides are transported with the help of SRP and its receptor on the ER-
surface (SRP-receptor, SR) [55–65]. SRP binds to nascent precursor
polypeptides as soon as their signal peptides emerge from the
translating ribosomes. This interaction slows down protein synthesis,
thereby allowing the complex of ribosome, nascent polypeptide chain,
and SRP to reach the SRP-receptor (SR) at the ER-membrane. Thus,
SRP is involved in ER-targeting, in addition to being a molecular
chaperone for the nascent polypeptide. Furthermore, the synthesis ofmany polypeptides is initiated on ribosomes that are continuously
attached to the ER-membrane [66–70]. In this case, SRP and cytosolic
chaperones may not be required for translocation. Here, polypeptides
that lack a signal peptide for ER-targeting may be recognized by the
nascent chain associated complex (NAC). This interaction may lead to
release of the translating ribosomes from the membrane and
completion of protein synthesis in the cytosol [71–76].
In Saccharomyces cerevisiae, SRP-dependent (cotranslational) and
Hsp70-dependent (posttranslational) pathways are equally impor-
tant. The cotranslational pathway is predominantly used by precursors
with more hydrophobic signal peptides [77]. In Trypanosoma brucei,
there appears to be a less-stringent selectivity between co- and post-
translational pathways compared to yeast. SRP and SR are essential
only for cotranslational membrane insertion of polytopic membrane
proteins [78]. There is a signiﬁcant amount of posttranslational protein
transport into the trypanosomal ER, and this mechanism can be
employed by many different precursor polypeptides in a parallel
manner to the SRP-dependent pathway [79]. However, it seems this
SRP-independent pathway is the only choice for precursors of GPI-
anchored membrane proteins, such as variant surface glycoprotein
(VSG) [79]. After analyzing the hydrophobicity of signal peptides of
GPI-anchored versus non-GPI-anchored proteins, it was suggested
that GPI-anchored membrane proteins are routed to the SRP-
independent pathway due to their less hydrophobic signal peptides
[8,79]. This is reminiscent of the situation in yeast [77]. This
specialization may be related to the abundance and speciﬁc role in
survival of trypanosomal GPI-anchored membrane proteins within its
two hosts (mammals and insects). In mammalian cells, the cotransla-
tional pathway appears to be the predominant one; however, the
mammalian ER has the capacity for posttranslational protein transport
[80–82]. The unifying feature of the posttranslationally transported
precursor polypeptides is that they contain less than 75 amino acid
residues, i.e. they are below the minimal size of a nascent polypeptide
chain to cotranslationally interact via its signal peptidewith SRP on the
ribosomal surface. However, posttranslational transport was also
observed for an artiﬁcial precursor, a hybrid between one of the small
precursors and the cytosolic protein, dihydrofolate reductase. Fur-
thermore, the SRP-independent and cotranslational mechanism may
bemore common than originally expected since RNAi-mediated knock
down of SRP subunits hardly affected protein secretion in trypano-
somes and some mammalian cell types [83–85].
As mentioned above, protein export from bacteria and archaea is
mechanistically related to protein transport into the ER [see Eichler,
Tommassen, and Driessen, this issue]. There are several evolutionarily
related transport components present in the plasma membrane of
bacteria and archaea and the ER membrane, and the signal peptides
are very similar in bacteria and eukaryotes (even inter-changeable in
some cases). Furthermore, the SRP/SRP-receptor system is mechanis-
tically conserved in bacteria and archaea, although it is dedicated to
cotranslational transport of precursors to polytopic membrane
proteins in bacteria [86].
3. Transport components
3.1. ER-resident protein translocases in yeast
In yeast cells, targeting or speciﬁc membrane association in
cotranslational transport involves SRP and its receptor on the ER
Table 1
Proteins and complexes that are involved in protein transport into the endoplasmic reticulum.
Function Homo sapiens Trypanosoma brucei Saccharomyces cerevisiae
Targeting machinery SRPa SRP SRP
7SL RNA 7SL RNA scR1 RNA
– sRNA-76 –
SRP72 SRP72 Srp72p
SRP68 SRP68 Srp68p
SRP54 SRP54 Srp54p
– – Srp21p
SRP19 SRP19 Sec65p
SRP14 – Srp14p
SRP9 – Srp7p
SRP-receptor (SR) SRP-receptor (SR) SRP-receptor (SR)
SRα (docking protein) SRα SRα
SRβ SRβ SRβ
Cytosolic or cis-acting chaperones Hsc70 Ssa1p
Hdj2 Ydj1p
Hsp40
Translocons Sec61-complex Sec61-complex Sec61-complex
Sec61α Sec61α Sec61p
Sec61β Sec61β Sbh1p
Sec61γ Sec61γ Sss1p
Alternative Sec61-complex – Alternative Sec61-complex
Sec61α2 Ssh1p
Sec61β Sbh2p
Sec61γ Sss1p
Auxiliary components TRAM protein ? –
TRAP-complex (SSR) ? –
TRAPα
TRAPβ
TRAPγ
TRAPδ
Sec62/63-complex Sec62/63-complex Sec62/63-complex
Sec62 (HTP1, TLOC1) – Sec62p
Sec63 (ERj2) Sec63 Sec63p (Ptl1p, Npl1p)
– Sec71 Sec66p (Sec71p)
– – Sec67p (Sec72p)
trans-acting chaperone trans-acting chaperone trans-acting chaperone
BiP (Grp78, HspA5) BiP Kar2p (BiP)
NEFs NEFs NEFs
Grp170 (Orp150, HYOU1) ? Lhs1p (Ssi1p, Cer1p)
Sil1 (BAP) ? Sil1p
Alternative Sec62/63-complex – –
ERj1 (Htj1, DNAJC1)
RAMP4 (SERP1) ? –
PAT-10 ? –
Modifying enzymes Signal peptidase complex (SPC) Signal peptidase complex (SPC) Signal peptidase complex (SPC)
Oligosaccharyl transferase (OST) Oligosaccharyl transferase (OST) Oligosaccharyl transferase (OST)
GPI-transamidase GPI-transamidase GPI-transamidase
a There is structural information from cryo-EM available for dimeric complexes of ribosomes and SRP [63], trimeric complexes of ribosomes, SRP, and SR [64], for dimeric
complexes of ribosomes and the Sec61 complex [155–160], for dimeric complexes of ribosomes and ERj1 [143], and for dimeric complexes for ribosomes and OST [18]. Furthermore,
there is structural information from X-ray analysis available for Hsp40- and Hsp70-proteins [120–125], SRP subunits [59–62], archaean SecY [161], for cytosolic Sil1 and Grp170-
homologous nucleotide exchange factors [125–128], for the cytosolic domain of Sec63 [111,112], and for the bacterial ortholog of the catalytic subunit of eukaryotic SPC [14].
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transport of precursor proteins involves a heterotrimeric complex of
membrane proteins, comprising Sec62p, Sec71p (alternative name:
Sec66p), and Sec72p (also termed Sec67p), that serves as a signal
peptide receptor (Table 1) [91–97]. In co- and posttranslational
translocation, membrane insertion and completion of translocation
occur at the level of the heterotrimeric Sec61 complex (comprising
Sec61p, Sbh1p, and Sss1p) and involve additional components, such
as the ER-lumenal chaperone, BiP (or Kar2p), its membrane receptor
and co-chaperone, Sec63, and its NEFs (Sil1p and Lhs1p) [91–128]. BiP
has roles in facilitating posttranslational insertion of precursor
polypeptides into the Sec61 complex and as a molecular ratchet in
the completion of translocation [115].
There is an additional heterotrimeric Sec61 complex present in the
yeast ER that acts alternatively to the above-mentioned Sec61 complex
in co- and posttranslational transport (termed here, alternative Sec61
complex; comprising Ssh1p, Sbh2p, and Sss1p) [103,104]. Like the
Sec61 complex, the alternative Sec61 complex is also involved in ERAD
[40–43,104].The genes coding for Sec61p, Ss1p, Sec62p, Sec63p, and Kar2p are
essential [91,98,106]. Non-lethal mutations in any one of these genes
results in temperature-sensitive mutants that at the restrictive
temperature accumulate precursor polypeptides in the cytosol and
are defective in protein secretion. Furthermore, simultaneous deletion
of both NEF genes results in synthetic lethality [120].
3.2. ER-resident protein translocases in trypanosomes
Recent work on the protein transport machinery located in the ER
of T. brucei identiﬁed homologues of many, but not all, of the
respective yeast proteins (Table 1) [78,79]. As in yeast, membrane
insertion and completion of translocation occur at the level of the
heterotrimeric Sec61 complex (comprising Sec61α1, Sec61ß, and
Sec61γ). The key observation from a RNAi approach, that included
analysis of secretion or membrane integration of different model
proteins, was that trypanosomal Sec63 and, by our inference,
trypanosomal BiP are involved in co- as well as posttranslational
transport [79]. As in yeast, Sec63 was found to be essential. The effect
Fig. 1. Hypothetical model for cotranslational and SRP & SR dependent protein transport into the mammalian ER. Note that cleavable signal peptides within nascent precursor
proteins insert into the Sec61 complex in a loop like fashion that orients the aminoterminus to the cytosol and the carboxyterminus plus the SPC cleavage site to the ER lumen.
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components of the SRP-dependent (SRP68) plus the Hsp70-depen-
dent (Sec71) pathways. Thus, this work provided the ﬁrst in vivo
support outside of yeast that these ER resident chaperones play a role
in cotranslational transport of precursor polypeptides into the ER.
Another important observation was that, of the signal peptide
receptor subunits involved in posttranslational transport into the
yeast ER [110], only the putative homologue of Sec71p is present in
the trypanosomal ER membrane, and this trypanosomal Sec71, in
contrast to the situation in yeast, is essential and relevant only for the
posttranslational pathway [79]. Therefore, it was found that mainly
the GPI-anchored membrane proteins, such as VSG, are affected by
silencing of SEC71.
3.3. ER-resident protein translocases in mammals
In mammalian cells, targeting or speciﬁc membrane association in
cotranslational transport involves SRP and its receptor on the ER
surface (SRP-receptor or SR) [55–65]. Membrane insertion and
completion of translocation occur at the level of the heterotrimeric
Sec61 complex (comprising Sec61α1, Sec61ß, and Sec61γ) and
involve additional components, most notably the ER-lumenal chap-
erone, BiP (Table 1) [129–138]. BiP's membrane receptors and co-
chaperone(s), Sec63 (and ERj1), and its NEFs (Sil1 and Grp170) may
be considered additional subunits of the ER-resident protein translo-
case in mammalian cells (Fig. 1) [38,39,139–143]. The same may be
true for mammalian Sec62 that forms a stable complex with Sec63
[139,140,144]. Based on in vitro experiments, BiP has roles in gating
the Sec61 channel [135,136,138], in facilitating insertion of precursor
polypeptides into the Sec61 complex [134], and in serving as a
molecular ratchet in the completion of translocation [133,137]. Fur-
thermore, there are several additional proteins in the mammalian ER
membrane considered as additional subunits of the ER-resident
protein translocase in mammalian cells, such as TRAM protein, the
TRAP complex (originally termed signal sequence receptor- or SSR-
complex), and PAT-10 protein (Table 1) [145–152]. Precursors with
long aminoterminal and long hydrophobic core regions showed a low
TRAM dependence [146].
There is a second SEC61-gene present in mammals, termed
SEC61A2. Thus, a second Sec61 complex may exist in the mammalian
ER, termed here the alternative Sec61 complex (comprising Sec61α2,
Sec61ß, and Sec61γ). Currently, however, there is no information
available on this complex.4. Structural information on ER-resident protein translocases
The ﬁrst structural insights into the composition of ER-resident
protein translocases came from analyses of the Sec61 complexes of
membrane proteins derived from microsomal detergent extracts,
ﬁrst for yeast microsomes and, subsequently, for canine pancreatic
microsomes. In yeast extracts, the Sec61-complex is found as a
monomer, dimer, and in complex with either Sec62, Sec63, Sec71,
and Sec72 (termed SEC complex) or Sec63, Sec71, and Sec72
(SEC prime complex). In canine pancreatic extracts, the Sec61-
complex is found as an oligomer [153] and to some extent in
complex with Sec62 and Sec63 [139,140].
More recent information on the composition of the protein transport
machinery present in the ER of mammalian cells came from ﬂuores-
cence resonance energy transfer (FRET) experiments that employed
ﬂuorescently labeled antibodies against translocase subunits, permea-
bilized MDCK-cells, and ﬂuorescence microscopy [154]. Results from
this approach supported the notion that heterotrimeric Sec61 com-
plexes are present as oligomers in mammalian ER membranes.
Furthermore, these data demonstrated that SR, TRAP, and TRAM are in
close proximity with Sec61 complexes in the course and absence of
protein translocation. An association of Sec61 complexes with TRAP
complexes was also observed in the most recent 3D-reconstructions
after cryo-EM (see below).
An additional criterion argues that certain mammalian ER mem-
brane proteins participate in cotranslational protein translocation, i.e.
ribosomal association in detergent extracts from mammalian micro-
somes. Originally, the term ribosome-associated membrane proteins or
RAMPs was coined for this class of membrane proteins (after
solubilization in the presence of 400 mM potassium chloride) [131].
The Sec61 complex is a RAMP, as is the protein RAMP4 [150,151]. More
recently, ERj1 and Sec62 were characterized as RAMPs, although their
ribosome association is seen only under more physiological salt
concentrations (up to 200 mM potassium chloride) and, therefore,
may be more dynamic as compared to the high-salt resistant RAMPs
[142–144]. This view is supported by quantitative ﬂuorescence
microscopy [144]. When various permeabilized mammalian cells were
incubated in the presence or absence of RNaseA and, subsequently, with
ﬂuorescently labeled antibodies, RAMPs were identiﬁed at the cellular
level by differential ﬂuorescence signals−/+ RNase. According to this
cell based assay, Sec61α1, Sec61ß, Sec62, and ERj1 are RAMPs, i.e. are
associated with ribosomes in the intact ER. Again, this association was
observed in the course and absence of protein translocation.
Fig. 2. Structural information for cotranslational transport into the mammalian ER. The 3D reconstructions after cryo-EM of translating ribosomes with the Sec61 complex (Sec61)
were taken from reference [143]. Views from the plane of the membrane (a) and the ER lumen (b).
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Over the last 14 years, cryo-EM became an increasingly powerful
tool for structural analysis of complexes between ribosomes and
protein transport components [155–160]. With respect to yeast and
mammalian Sec61 complexes, the original 3D-reconstructions gave
rise to a model where two to four heterotrimeric Sec61 complexes
with an overall diameter of about 10 nm were associated with the
tunnel exit of a single ribosome in the presence or absence of
a nascent precursor polypeptide chain (resolution: about 25
Angström) (Fig. 2) [155,156]. Current data from a higher resolution,
reached with the most advanced microscopes and state of the art
algorithms, indicates a single heterodimeric Sec61 complex is
associated with a single ribosome and that the originally observed
additional mass was due to lipids and detergent molecules
(resolution: 9–11 Angström) [159,160]. The most recent recon-
structions are consistent with a postulate, based on the X-ray
analysis of an inactive archaean SecY complex (see below),
suggesting polypeptide translocation occurs in the central pore of
a heterotrimeric Sec61 complex. Furthermore, the more recent
reconstructions also described complexes between ribosomes, the
Sec61 complex, and the TRAP complex [159].
The 3D-reconstructions after cryo-EM also provided insights into
the intimate contacts between the ribosomal tunnel exit and the
Sec61 complex. At the level of the ribosomes, rpl23a (in yeast rpl25)
and rpl35 were identiﬁed as the nearest neighbors of the Sec61
complex. At the level of the Sec61 complex, cytosolic loops 6 and 8,
formed between transmembrane segments 6 and 7, and 8 and 9,
respectively, were characterized as interaction sites with the
ribosome. These results were consistent with previous biochemical
experiments [65,153]. In addition, these recent structural data cast
doubt on the view that the intimate contacts between ribosomes and
the Sec61 complex are sufﬁcient to prevent ion efﬂux from the ER
lumen during cotranslational protein translocation. In fact, there is a
large gap between the ribosomal surface near the tunnel exit and the
cytosolic surface of the Sec61 complex.
4.2. Crystallization and X-ray analysis
In 2004 the ﬁrst, and so far only, structure of a Sec61 complex
family member was solved by crystallization and subsequent X-ray
analysis (resolution: 3.2 Angström) [161] for the heterotrimeric SecY
complex from the archaeMethanococcus jannaschii (comprisingα-, ß-
, and γ-subunits). The structure was characterized as two covalently
linked halves of the α-subunit that were clamped together by the γ-subunit and contained an hourglass shaped central pore and an
overall diameter of about 4 nm. Due to the similarity between the
subunits of the archaen SecY complex and the mammalian Sec61
complex, molecular modeling allowed us to create a homology model
for the human heterotrimeric Sec61 complex that is more or less
indistinguishable from the SecY structure (Fig. 3). Since the
crystallized complex did not contain any precursor polypeptides in
transit, it was proposed that (i) the central pore within the α-subunit
is the site for protein translocation, (ii) the central pore can laterally
open towards the side opposite to the clamp provided by the γ-
subunit, to allow lateral exit of signal peptides from the pore [162],
and (iii) constriction between the two funnels of the hourglass was
plugged by a short helix [161]. Furthermore, it was proposed that the
constriction can be widened by a conformational change that results
in plug displacement and simultaneous generation of a pore for the
polypeptide in transit that is lined at the constriction site by a ring of
hydrophobic residues. It was suggested that the potential pore had a
maximal internal diameter of up to 0.8 nm, i.e. dimensions that can
accommodate an unfolded polypeptide chain or a single α-helix.
4.3. Electrophysiological data
In addition to direct structural methods, the structure of the
mammalian Sec61 complex was also addressed by indirect methods,
such as electrophysiological approaches (single channel recordings
from planar lipid bilayers) [163–166]. This technique was ﬁrst applied
by Simon and Blobel in 1989 [163]. The Sec61 complex had not yet
been identiﬁed and the canine pancreatic channel that was charac-
terized correlated with protein translocation and was termed the
protein-conducting channel (PCC) with an internal diameter of about
1 nm. More recently, this approach was applied to the puriﬁed and
reconstituted canine pancreatic Sec61 complex. The complex was
characterized as an aqueous pore that is transiently opened by signal
peptides within precursor polypeptides at early and the ﬁnal stages of
protein translocation and closes either spontaneously or as triggered
by BiP [165]. In the open state, two internal pore diameters were
observed with the highest frequency for this highly dynamic channel,
and corresponded to mean values of 1.2 and 2.2 nm, respectively (full
range: 0.6 to 6 nm). Internal pore diameters of 4 to 6 nm had
previously been observed in ﬂuorescence quenching experiments,
however, without directly linking these channels to the Sec61
complex [167,168]. Furthermore, these ﬂuorescence quenching
experiments identiﬁed BiP as a lumenal plug of the mammalian
Sec61 complex and suggested that an unidentiﬁed Hsp40-type co-
chaperone of BiP is involved in this reaction [135,136,138].
Fig. 3. Homology model for the human heterotrimeric Sec61 complex. (a, b) Views from the plane of the membrane (a, front) and the cytosol (b). Transmembrane helices (TM)
forming the front of the lateral gate and the plug, respectively, are indicated in colour. (c, d) Distribution of polar residues (shown in red) on the external surface of the front (c) and
the back (d). As no structural information is available for human Sec61, a homology model was generated using the X-ray structure of archaean SecY (PDB code: 1rhz [161]) as a
template. The amino acid sequence of human Sec61 and its sequence alignment with bacterial SecY were taken from [161]. Ten homology models were generated by the program
MODELLER 9.5 using an all-hydrogen model. Each model was optimized with the variable target function method, followed by a reﬁnement step using molecular dynamics with
simulated annealing. The whole optimization procedure was repeated three times and the best model was selected according to the molecular probability density function score. We
note that according to this homology model, the constriction site of the human complex is lined by a ring of hydrophobic residues, too.
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5.1. In cotranslational translocation
Various types of evidence demonstrate a strong interaction
between ribosomes and Sec61 complexes. These range from
biochemical assays that led to the deﬁnition of RAMPs to the 3D-
reconstructions after cryo EM of ribosome/Sec61 complexes
[131,155,156]. Therefore, it is safe to conclude that cotranslational
translocation of polypeptides into the ER is driven by elongation of
the nascent polypeptide chain, i.e. the hydrolysis of GTP, at least at
certain stages.
However, when translation is terminated there are still about 70
amino acid residues of the nascent polypeptide chain outside of the
ER, i.e. buried in the ribosomal tunnel and the polypeptide
conducting channel within the heterotrimeric Sec61 complex.
Since movement of polypeptides through the Sec61 complex is
reversible [169], complete translocation of this carboxyterminal
peptide may require help from an ER lumenal polypeptide bindingprotein (molecular ratchet, see below). In principle, any ER lumenal
protein with a binding site for unfolded polypeptides may be able to
fulﬁll this function, such as OST, SPC, GPI transamidase, protein
disulﬁde isomerase (PDI), or peptidyl-cis/trans-isomerase (PPIase).
Indeed, nascent polypeptides in transit through the Sec61 complex
could be cross-linked to protein disulﬁde isomerases and peptidyl-
cis/trans-isomerase immediately after their release from the
translating ribosomes [170,171]. This point was driven home by
the observation that the efﬁciency of cotranslational protein
transport into mammalian microsomes can be artiﬁcially increased
by incorporation of biotin into nascent precursor polypeptides and
by trapping of avidin in the reconstituted microsomes (of note:
avidin had no effect in the absence of biotinylation) [137]. However,
there is no doubt that the ER lumenal chaperone, BiP, is ideally
suited to fulﬁll this function, since it can be recruited to the
ribosomal tunnel and the polypeptide conducting channel within
the heterotrimeric Sec61 complex and simultaneously be activated
on demand. Indeed, BiP had the same effect as avidin on import into
reconstituted microsomes in the absence of biotinylation of nascent
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as the hydrolysis of ATP by the ATPase, BiP. This view is consistent
with the Hsp40-type co-chaperone of BiP, Sec63, being involved in
cotranslational protein transport of precursor proteins in yeast and
trypanosomes [79,107,108]. Alternatively, three-dimensional fold-
ing of the aminoterminal peptide of a polypeptide chain in transit
may drive translocation of the carboxyterminal peptide. Obviously,
the relevance of this alternative driving force increases with the
overall mass of the precursor protein. As a rule, small presecretory
proteins may be better candidates for relying on BiP for the
completion of cotranslational translocation.
5.2. In posttranslational translocation
Posttranslational translocation is very similar to completion of
translocation of carboxyterminal peptides in cotranslational translo-
cation, except that the precursor polypeptide has to ﬁrst be inserted
into the Sec61 complex. Posttranslational translocation of precursor
polypeptides has most extensively been characterized in yeast. ATP
and BiP were required for the insertion of precursor polypeptides into
the Sec61 complex as well as for the completion of translocation into
the ER [113–116]. Furthermore, these reactions involved the Hsp40-
type co-chaperone of BiP, Sec63p, as well as the two NEFs, Sil1p and
Lhs1p [109,117,118]. These results are consistent with recent ﬁndings
for posttranslational protein transport into the trypanosomal ER [79].
Molecular chaperones of the Hsp70 type family reversibly bind to
substrate polypeptides via their substrate binding domains (SBD)
[172–174]. Hsp70 binds to hydrophobic stretches within essentially
unfolded polypeptides, such as those emerging from ribosomal
tunnels or aqueous protein conducting channels [175,176]. The
binding and release of substrates by Hsp70 are modulated by
communication between its SBD and its nucleotide binding-domain
(NBD). Furthermore, the NBD is controlled by the ATPase cycle and
different Hsp70 interaction partners [120–128]. The ATP-bound state
of BiP has a low afﬁnity for substrate polypeptides and the ADP-bound
state has a high substrate afﬁnity. Hsp40-type co-chaperones
stimulate the ATPase activity, as they favor substrate binding.
Nucleotide exchange factors stimulate the exchange of ADP for ATP
and, therefore, induce substrate release. Hsp40 proteins are charac-
terized by J-domains that allow interaction with Hsp70 [177–183].
Accordingly, a role for BiP in early and late stages of posttransla-
tional translocation can be envisaged, where immediately after the
reversible insertion of a precursor polypeptide into the Sec61 complex,
it binds to the aminoterminal end and, thereby, prevents back-sliding
into the cytosol (Fig. 1). Subsequently, the precursor becomes stepwise
inserted into the Sec61 complex and, thereby, increasingly trapped in
the lumen, as was ﬁrst described in the molecular ratchet model for
posttranslational import of precursor proteins into mitochondria. This
point was driven home by the observation that the efﬁciency of
posttranslational protein transport into yeast microsomes can be
artiﬁcially increased by trapping precursor polypeptide-speciﬁc anti-
bodies in the reconstituted microsomes [116]. In addition, BiP may be
involved in opening of the Sec61 complex, i.e. in triggering the con-
formational changes in the heterotrimeric Sec61 complex that lead to
plug displacement and allowing the insertion of a precursor polypep-
tide into the complex.
5.3. In special cases
The hepatitis B virus (HBV) L protein represents an interesting
example of posttranslational translocation of a large soluble domain
across the mammalian ER membrane [184]. Originally, it is integrated
into the ER membrane in a typical cotranslational process that is
determined by an internal signal peptide, located in the carboxy-
terminal region of the aminoterminal domain. Its aminoterminal pre-
S domain, with an overall size of 168 amino acid residues, remainscytosolic. In the course of maturation, about half of the L molecules
posttranslationally translocate their preS domain into the ER, thereby
creating a dual topology that is maintained in the secreted virion
envelope and allows the L protein to fulﬁll a dual function. The
interesting feature, in the context of this review, is that translocation
of the preS domain is driven by BiP, i.e. the hydrolysis of ATP [185].
Furthermore, this process involves an ER membrane resident Hsp40-
type co-chaperone, ERj4, and the NEF, Sil1. Biogenesis of the
adenovirus E3-6.7 K protein, the hepatitis C virus (HCV) NS4B protein,
and the non-viral aquaporin-1 appears to involve similar posttrans-
lational processes [186–188].
6. Insertion of proteins into the ER membrane
The insertion of membrane proteins into the ER membrane is the
ﬁrst step in the biogenesis of most plasma membrane and organelle
membrane proteins of eukaryotic cells (such as membrane proteins of
the ER, ER-Golgi intermediate compartment/ERGIC, Golgi, endosome,
lysosome, and peroxisome). In general, this process is seen as a
variation of protein translocation across the ER membrane [189] that
typically does not involve cleavable signal peptides. Exceptions of this
are precursors of type I membrane proteins that contain cleavable
signal peptides and are inserted into the Sec61 complex in analogy to
presecretory proteins and processed by SPC to a mature form with an
orientation in the membrane where the aminoterminus faces the ER
lumen. Instead, the ﬁrst potential membrane spanning peptide within
the nascent precursor polypeptide chain that emerges at the
ribosomal tunnel exit serves as the signal peptide. This non-cleavable
signal peptide can insert into the Sec61 complex, like a cleavable
signal peptide, in a loop like fashion and lead to an orientation in the
membranewhere the aminoterminus faces the cytosol (termed type II
membrane protein). Alternatively, the non-cleavable signal peptide
can insert into the Sec61 complex head-on and lead to an orientation
in the membrane where the aminoterminus faces the ER lumen
(termed type I membrane protein). The features that determine the
particular mode of insertion are described by the “positive inside rule”
[190]. Subsequently-emerging membrane spanning peptides in
double-spanning and polytopic membrane proteins alternately arrest
and re-initiate translocation [191–197]. The term stop-transfer
sequence was coined to characterize the arrest function of every
second membrane spanning peptide in the latter membrane proteins.
Inmembrane insertion, futuremembrane spanning peptides leave the
Sec61 complex through the lateral gate laterally into the lipid bilayer;
this is in contrast to protein translocation.
The features that govern lateral release of a future membrane
spanning peptide were recently characterized in detail [198–201]. In
particular, extensive studies on the leader peptidase protein have
characterized the membrane insertion efﬁciencies of a third engi-
neered transmembrane segment, the so-called H-segment [199,201],
where the 20 naturally occurring amino acids were inserted at
different positions with respect to the bilayer center. The observed
insertion efﬁciencies were converted into an apparent free energy
scale for insertion, termed the “biological scale.” Some amino acids
showed strong position dependence between the hydrophobic core
and the polar interface area [201]. A computational model accounting
for this position dependence could well reproduce the measured data
suggesting that the insertion efﬁciency of a putative transmembrane
segment simply depends on the sum of the insertion free energies of
the individual amino acids [202–204]. Interestingly, an alternative
statistical model for the membrane insertion free energies derived
from the distribution of amino acids in the known three-dimensional
structures of helical TM proteins agrees well with the model derived
from the H-segment data [202]. This supports the transferability of the
“biological scale” to a wide range of helical TM architectures.
Sofar, we have discussed the insertion of transmembrane helices
one-by-one. In fact, experimental data suggested that up to four
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the same time [205,206]. Obviously, many membrane transporters
and channels need to allow passage of polar substrate molecules
through a central pore lined by mostly polar residues. If all the pore-
lining helices carrying these polar residues had to be released one-by-
one from the translocon into the lipid bilayer, this would often be
quite unfavorable. In fact, it was shown that the average insertion free
energies for TM helices from polytopic membrane proteins are less
favorable than for single TM-spanning helices in bitopic membrane
proteins [202,203]. Moreover, cooperative effects may even occur
between TM helices of different proteins. An example for this is the
heterodimer formed by the E1- and E2-glycoproteins of hepatitis C
virus. The genes coding for these two proteins are direct neighbors on
the HCV genome and are translated as a continuous chain. Upon
passage through the translocon, the two protein chains are cleaved
and inserted into the membrane. The E1 proteins in the ﬂaviviridae
family contain a highly conserved positively charged Lys residue in
their TM segment and the E2 proteins contain a highly conserved
negative Asp residue in the TM part. According to the biological scale,
insertion of the individual E1 and E2 helices would be very
unfavorable. Mutagenesis results, however, support the formation of
an inter-helical salt bridge between the E1 and E2 helices leading to a
strong stabilization of the E1–E2 dimer [207,208]. Molecular model-
ling supported the important role of this ion-pair in the center of the
membrane for the cooperative insertion by the translocon and for the
stability of this TM dimer [209]. In summary, the data on H-segments
show that the general decision whether a part of a protein chain is
inserted into the lipid bilayer or translocated is primarily based on
simple physico-chemical principles. On a second level, this apparent
simplicity is modulated by cooperative effects between sequential
helices that is subject of on-going experimental and computational
studies. For example, molecular dynamics simulations of protein-
loaded membranes showed that cooperative interactions with
neighboring membrane proteins may signiﬁcantly affect the mea-
sured values for individual TM segments [210].
Still, it remains unclear if the Sec61 complex alone or together with
the lipid bilayer provides the read out. At the lateral release of future
membrane spanning peptides, single peptides, pairs, or multimers of
peptides may exit the Sec61 complex. Thus, in the two latter cases, the
Sec61 complex also contributes to the foldingof transmembraneproteins.
7. Medical aspects
7.1. Pharmacology
Recent work in several laboratories identiﬁed a number of small
molecule inhibitors of co- and posttranslational protein transport in the
yeast, trypanosomal, and mammalian ER. The inhibitors fall into two
categories, inhibitors of theSec61complex and inhibitorsofBiP. Theﬁrst
class of molecules to be discovered as Sec61 inhibitors was the group
of cyclodexipeptides, such as Cotransin, CAM741, and Apratoxin A
[211–213]. The pharmacological potential of cotransin and CAM741 is
that these compounds selectively inhibit surface expression of vascular
cell adhesion molecule 1 (VCAM1), i.e. may be used in ﬁghting chronic
inﬂammatory conditions. Apratoxin A is a potential anti-cancer drug.
More recently, Eeyarestatin I, originally described as an inhibitor of
protein export from the ER, was added to this growing list [214]. All four
inhibitors seem to directly affect the Sec61 complex with respect to
cotranslational transport in vitro as well as at the cellular level. It was
suggested that Eeyarestatin I exerts its effect at a stage prior to the site of
action of the cyclodexipeptides [214].
There are many different small molecules that affect Hsp70-type
molecular chaperones at different stages of their functional cycle.
Most of these represent variants of 15-deoxyspergualin and NSC
630668-R/1. Two of these compounds were found to interfere with
the Hsp70/Hsp40 interaction and to inhibit posttranslational proteintranslocation into yeast microsomes (MAL3-39 and MAL3-101) and
trypanosomal microsomes (MAL3-101), respectively [215,216].
Furthermore, it was observed that the inhibitor of bacterial protein
SecA, CJ-21,058 and its variant equisetin, inhibit posttranslational
protein translocation into trypanosomal microsomes [216]. However,
in theses cases the drug target is currently unknown. The latter two
inhibitors of posttranslational transport of precursor proteins, such as
VSG, were also shown to kill bloodstream trypanosomes in vitro and,
therefore, were characterized as potential lead compounds for anti-
trypanosome drug development.
Findings on the composition of protein translocase in the trypano-
somal ER are also of potential pharmacological relevance because of the
apparent absence of a Sec71p homologue in human cells [79]. We note,
however, that so far, onlyprocyclic- andnot bloodstream-trypanosomes
have been investigated; therefore, the observed Sec71 dependence of
GPI-anchored membrane protein biogenesis may not exist for blood-
stream trypanosomes. However, if trypanosomal Sec71 could be
speciﬁcally targeted by small molecules in a mammalian host, a related
anti-trypanosomal drug would become feasible.
7.2. Diseases
Most recently, two diseases were linked to the mammalian Sec61
complex. A point mutation in the SEC61A1 gene was found to cause
diabetes and hepatosteatosis in mice, suggesting some human type 2
diabetes patients may suffer frommutations in the SEC61A1 gene [217].
In this disease model, the mutation did not directly affect protein
translocation but led to ER stress and subsequent ß-cell apoptosis.
The SEC61γ gene was among the most frequently ampliﬁed genes
in the most prevalent type of adult brain tumors, glioblastoma
multiforme [218]. Overexpression was observed for 77% of glioblas-
toma multiforme, but not for lower-grade gliomas. Previously, similar
results were obtained for the SEC62 gene in association with prostate
cancer [219], while, the SEC63 gene was found to be among the most
frequently mutated genes in cancers with deﬁcient DNA mismatch
repair, such as hereditary nonpolyposis colorectal cancer (HNPCC)-
associated small-bowel cancer, and in sporadic gastric and colorectal
cancers with frequent microsatellite instability [220–222].
Furthermore, loss of function mutations were linked to polycystic
liver disease (SEC63 gene) and the neurodegenerative disease termed
Marinesco–Sjögren syndrome (SIL1 gene) [223–227]. Both diseases
are thought to result from loss of function of both alleles, but
apparently have opposite effects on the respective target cells,
progressive cerebellar atrophy with ataxia due to Purkinje cell loss
in Marinesco–Sjögren syndrome and progressive development of
biliary epithelial cysts throughout the liver due to cell proliferation in
polycystic liver disease.
Last but not least, Shiga toxigenic Escherichia coli strains can cause
massive morbidity and mortality. Typically, these pathogens produce
AB5 toxin (also termed subtilase AB) and are responsible for
gastrointestinal diseases, such as the life-threatening hemolytic
uremic syndrome. The B-subunit pentamer binds to toxin receptors
on the cell surface, while the A-subunit has subtilase-like serine
protease activity [228]. During an infection, the bacterial cytotoxin
enters human cells by endocytosis, followed by retrograde transport
to the ER. In the ER, BiP is the major target of the catalytic A-subunit,
which inactivates BiP by limited proteolysis. Eventually, all BiP
functions are completely lost and the affected cells die.
8. Conclusions
The mechanism of protein translocation into the ER is reasonably
well understood in general terms, but is far from being completely
explained. It is clear that the Sec61 complex provides the aqueous
path for the entry of soluble polypeptides into the ER lumen as well as
the lateral entry of membrane proteins into the ER membrane (with
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[Borgese, this issue]. Based (i) on the effects of small molecule
inhibitors on the mammalian Sec61 complex, (ii) on the presence of
different SEC complexes in yeast, (iii) on differential effects of
mutations or gene silencing in yeast and trypanosomes, respectively,
and iv) on the differential effects of disease-causing mutations in
humans, it has to be concluded that different precursor polypeptides
pose different demands to the protein transport machinery of the ER
in eukaryotic cells. Thismanifests itself at the atomic level of the Sec61
complex and additional transport components, such as BiP+Sec63,
TRAM protein, etc. (Table 1). Therefore, the functions of all these
auxiliary components will have to be elucidated to reach the next
level of understanding. Yet another level of heterogeneity can
undoubtedly be expected when questions related to the regulation
of protein translocation into the ER in different cell types of the human
body are seriously addressed. This will almost certainly also shed light
on related processes, such as protein insertion into the ER membrane
and ER protein export (ERAD).
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